2024 HCPCS Code C9760
Non-randomized, non-blinded procedure for nyha class ii, iii, iv heart failure; transcatheter implantation of interatrial shunt, including right and left heart catheterization, transeptal puncture, trans-esophageal echocardiography (tee)/intracardiac echocardiography (ice), and all imaging with or without guidance (e.g., ultrasound, fluoroscopy), performed in an approved investigational device exemption (ide) study
TAGS: investigational device interatrial guidance right exemption imaging performed transcatheter transeptal approved class echocardiography procedure heart implantation study
Short Description | Non-blind interatrial shunt |
HCPCS Coverage Code | D - Special coverage instructions apply |
HCPCS Action Code | N - No maintenance for this code |
HCPCS Action Effective Date | January 01, 2021 |
HCPCS Code Added Date | July 01, 2020 |
HCPCS Pricing Indicator Code | 53 - Statute |
HCPCS Multiple Pricing Indicator Code | A - Not applicable as HCPCS priced under one methodology |
HCPCS Coverage Issues Manual Reference Section Number | |
HCPCS Type Of Service Code | 2 - Surgery |
HCPCS Anesthesia Base Unit Quantity | 0 |
Check Similar HCPCS Codes
- C9014 - Injection, cerliponase alfa
- C9015 - C-1 esterase, haegarda
- C9016 - Inj, triptorelin ext rel
- C9021 - Injection, obinutuzumab
- C9022 - Injection, elosulfase alfa
- C9023 - Inj testosterone undecanoate
- C9024 - Inj, daunorubicin-cytarabine
- C9025 - Injection, ramucirumab
- C9026 - Injection, vedolizumab
- C9027 - Injection, pembrolizumab
- C9028 - Inj. inotuzumab ozogamicin
- C9029 - Injection, guselkumab
- C9030 - Inj copanlisib
- C9031 - Lutetium lu 177 dotatate, tx
- C9032 - Voretigene neparvovec-rzyl
- C9033 - Inj, akynzeo
- C9034 - Injection, dexamethasone 9%
- C9035 - Injection, aristada initio
- C9036 - Injection, patisiran
- C9037 - Injection, risperidone